LIVE
⭐5M influencer listings 🏢60K sponsor listings 🌍75.2B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋2.2M Bluesky creators 🎙️1.2M podcast creators 🟣860.9K Twitch creators 🐘166.2K Mastodon creators 📈128.2K Pinterest creators 🥊123.7K Kick creators 𝕏105.6K X creators ▶️90.5K YouTube creators ✈️61.2K Telegram creators 🎵44.4K TikTok creators 🎮9.1K Discord creators 🎬4.4K Rumble creators 📈2.5K Substack creators 🧵1.8K Threads creators ⭐5M influencer listings 🏢60K sponsor listings 🌍75.2B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋2.2M Bluesky creators 🎙️1.2M podcast creators 🟣860.9K Twitch creators 🐘166.2K Mastodon creators 📈128.2K Pinterest creators 🥊123.7K Kick creators 𝕏105.6K X creators ▶️90.5K YouTube creators ✈️61.2K Telegram creators 🎵44.4K TikTok creators 🎮9.1K Discord creators 🎬4.4K Rumble creators 📈2.5K Substack creators 🧵1.8K Threads creators
The Lancet

The Lancet✓

X @thelancet
⚔ Compare ☆ Follow Own this channel?
🔄 Data last refreshed 20 hours ago
🤝

Make a deal with The Lancet

🔒 Paid proposals held safely in escrow — released only when the work's approved.

📣Sponsored postOne tweet with your link and creative. $6,063→ 🧵Sponsored threadA multi-tweet thread — X rewards long-form, threads out-reac… $15,158→ 🎬Sponsored video postA dedicated video tweet — X pushes video hard, so it gets pr… $8,488→ 📌Pinned postA sponsored post pinned to the top of my profile for the mon… $18,189/mo→ 📍Post + pin comboA sponsored post that also stays pinned for a set number of … $9,701→ 🔁Repost / quote-tweet packageI repost or quote-tweet your posts through the month — distr… $12,126/mo→ 🔗Bio link placementYour link in my bio for the month — X allows only one, so it… $9,095/mo→ 🎙️X Spaces appearance / hostI host or feature you in an X Space (live audio) — a branded… $12,126→ 🤝Cross-promo / mutual shoutoutWe shout each other out — a value swap between accounts. Swap→ 🎬UGC HireBranded content for your own channels & ads from $2,653→ 🎙️Podcast guest spotInvite The Lancet onto your podcast (~45 min, remote) $2,652→ 📞1:1 ConsultPaid video call — advice, coaching or Q&A $424/hr→

Every booking is a normal escrow-protected deal.

Followers
757.8K
Posts
28K
Following
455
Account age
17 yrs
🎁 Free analysisfor The Lancet
🕵️Fake Followers CheckReal-audience % & bot risk→ 📊Engagement rateBenchmarked vs. peers→ 💰What they chargeFair sponsored-post price→

Known for

Taking a common diabetes medication after testing positive for SARS-CoV-2 reduces risk of developing #longCOVID by 40%, new study in @TheLancetInfDis finds https://t.co/0V4tBHUnp8 566.8K views Taking a common diabetes medication after testing positive for SARS-CoV-2 reduces risk of developing #longCOVID by 40%, new study in @TheLancetInfDis finds https://t.co/0V4tBHUnp8 The spread of health misinformation and disinformation poses a serious threat to public health. How can we respond to the danger and combat the tide of misinformation and disinformation to protect public health? Find out more in our latest Editorial: https://t.co/5PDk66YOfw 518K views The spread of health misinformation and disinformation poses a serious threat to public health. How can we respond to the danger and combat the tide of misinformation and disinformation to protect public health? Find out more in our latest Editorial: https://t.co/5PDk66YOfw Skin diseases affect far more than what we can see. A new Editorial examines how advances in dermatology can deliver greater clinical benefit—from more representative clinical trials to better measurement of stigma and quality of life. Read this & more: https://t.co/PA6XL4mSal 22K views Skin diseases affect far more than what we can see. A new Editorial examines how advances in dermatology can deliver greater clinical benefit—from more representative clinical trials to better measurement of stigma and quality of life. Read this & more: https://t.co/PA6XL4mSal

📊 Post performance

518K
Avg views / post
68.4%
Reach vs followers
Mar 2009
On X since

🔥 Top post: Taking a common diabetes medication after testing positive for S · 566.8K views

📊 Activity & format

Posting cadence
0.05 / week
A lower-frequency account — each post lands with more weight.
Content mix
Mostly images
Recent: 0 video · 18 image · 0 text.
Follower / following
1.7K×
Follows 455 back. A strong ratio — an audience that follows them, not a follow-for-follow network.
Verification
✓ X Premium
A paid X Premium (Blue) verified account.

Recent posts

View on X ↗
🔥 Top post Taking a common diabetes medication after testing positive for SARS-CoV-2 reduces risk of developing #longCOVID by 40%, new study in @TheLancetInfDis finds https://t.co/0V4tBHUnp8 566.8K❤ 2.4K🔁 996
Skin diseases affect far more than what we can see. A new Editorial examines how advances in dermatology can deliver greater clinical benefit—from more representative clinical trials to better measurement of stigma and quality of life. R… 22K❤ 75🔁 26 The spread of health misinformation and disinformation poses a serious threat to public health. How can we respond to the danger and combat the tide of misinformation and disinformation to protect public health? Find out more in our late… 518K❤ 2.2K🔁 1.4K On the cover, our Editorial: Why Roe v. Wade must be defended https://t.co/tj3UWXc6ll ❤ 9.9K🔁 3.9K NEW—Cervical cancer rates 87% lower in women offered vaccination against human papillomavirus (#HPV) between ages 12-13 than in previous generations, English study confirms. First direct evidence of cervical cancer prevention using bivale… ❤ 3K🔁 1.4K NEW—Almost all #COVID19 restrictions are set to end in England on July 19. A group of scientists and health experts outline 5 key concerns and urge delaying complete re-opening until everyone—including the young—is better protected. Read … ❤ 4.8K🔁 3.3K NEW—One in three #COVID19 survivors received a neurological or psychiatric diagnosis within six months of infection, an observational study of more than 230,000 patient health records published in @TheLancetPsych estimates. Read https://t.… ❤ 2.6K🔁 1.9K NEW—Interim analysis of Russian #COVID19 #vaccine phase 3 trial involving nearly 20,000 participants suggests a two-dose regimen has an efficacy of 91.6% against symptomatic #COVID19. No serious adverse events were deemed to be associated … ❤ 18.5K🔁 9.8K NEW Correspondence—80+ researchers warn that a so-called #herdimmunity approach to managing #COVID19 is “a dangerous fallacy unsupported by the scientific evidence” #WCPH2020 https://t.co/2gTtklAkwx ❤ 4.7K🔁 3.5K NEW—UK’s #COVID19 vaccine is safe and induces an immune reaction, according to preliminary results https://t.co/rDPlB9fDKr ❤ 16.7K🔁 8.6K Today, three of the authors have retracted "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" Read the Retraction notice and statement from The Lancet https://t.co/p… ❤ 8.5K🔁 7.5K We have published an Expression of Concern on the paper by Mehra et al on hydroxychloroquine and chloroquine published on May 22, 2020 https://t.co/yQ9irhRHxx ❤ 2.7K🔁 2.1K

💡 Facts

🗓️Joined X in 2009 — 17 years ago.
👁️Averages 518K views per post.
📤Posts about 0.1× per week.
💬1.19% engagement rate.
🏅Earned the 100K Followers for passing 100K followers.

🕵️ Fake follower check

Estimated
69/100
Good Credibility score
85%
Real Real audience
Low Fake-follower risk
High Data confidence
  • Est. 85% real, active audience · Low fake-follower risk.
  • Engagement (~0.7× of followers engage each post) is around typical for X.
  • Organic base — far more followers than accounts it follows.
  • Verified account.
  • Established account (17+ years old).
  • 1.19% engagement — below the ~14.4% typical for this size.

Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.

About

Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823.

📸 Gallery

Skin diseases affect far more than what we can see. A new Editorial examines how advances in dermatology can deliver greater clinical benefit—from more representative clinical trials to better measurement of stigma and quality of life. Read this & more: https://t.co/PA6XL4mSal The spread of health misinformation and disinformation poses a serious threat to public health. How can we respond to the danger and combat the tide of misinformation and disinformation to protect public health? Find out more in our latest Editorial: https://t.co/5PDk66YOfw Taking a common diabetes medication after testing positive for SARS-CoV-2 reduces risk of developing #longCOVID by 40%, new study in @TheLancetInfDis finds https://t.co/0V4tBHUnp8 On the cover, our Editorial: Why Roe v. Wade must be defended https://t.co/tj3UWXc6ll NEW—Cervical cancer rates 87% lower in women offered vaccination against human papillomavirus (#HPV) between ages 12-13 than in previous generations, English study confirms. First direct evidence of cervical cancer prevention using bivalent vaccine: https://t.co/HdQbGIKxZp NEW—Almost all #COVID19 restrictions are set to end in England on July 19. A group of scientists and health experts outline 5 key concerns and urge delaying complete re-opening until everyone—including the young—is better protected. Read https://t.co/mNy4UN1Btf. @dgurdasani1 NEW—One in three #COVID19 survivors received a neurological or psychiatric diagnosis within six months of infection, an observational study of more than 230,000 patient health records published in @TheLancetPsych estimates. Read https://t.co/995Qs1TQzj NEW—Interim analysis of Russian #COVID19 #vaccine phase 3 trial involving nearly 20,000 participants suggests a two-dose regimen has an efficacy of 91.6% against symptomatic #COVID19. No serious adverse events were deemed to be associated with vaccination. https://t.co/40sM7f2nbS

🔀 Audience overlap

Estimated

Estimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.

Ubisoft FR 🇫🇷 Ubisoft FR 🇫🇷 18% 桐生ココ🐉ホロライブ卒業生 桐生ココ🐉ホロライブ卒業生 18% Manu Raju Manu Raju 16% 草彅 剛 草彅 剛 15% Samaritans Samaritans 15% Tom Segura AKA Mr. Ladybug Tom Segura AKA Mr. Ladybug 15%

More like this

Find more →
X ＋
草彅 剛
草彅 剛 ✓
@ksngtysofficial
757.8K Followers
X ＋
Manu Raju
Manu Raju ✓
@mkraju
595.8K Followers
X ＋
Samaritans
Samaritans
@samaritans
171.3K Followers
X ＋
Ubisoft FR 🇫🇷
Ubisoft FR 🇫🇷 ✓
@ubisoftfr
1.2M Followers
X ＋
Tom Segura AKA Mr. Ladybug
Tom Segura AKA Mr. Ladybug ✓
@tomsegura
948K Followers
X ＋
桐生ココ🐉ホロライブ卒業生
桐生ココ🐉ホロライブ卒業生 ✓
@kiryucoco
758.2K Followers

Frequently asked questions

How much does The Lancet charge for a sponsorship?
The Lancet hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.
How do I contact The Lancet for a brand deal or collaboration?
Send a paid deal or collab request right here on SocialDB — we notify The Lancet, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.
How many followers does The Lancet have?
The Lancet has 757,847 followers on X.

✉ Message The Lancet

Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.

  • ✓ Message any influencer from their listing
  • ✓ The influencer gets notified by email
  • ✓ Manage every conversation in one inbox
See Pro $9.95/mo →

Already Pro? Log in.

🎤 Event / appearance with The Lancet

Booking an event / appearance is a Pro feature. Upgrade to book The Lancet for an in-person or virtual appearance — payment held safely in escrow until the event is done.

  • ✓ Book them for events, livestreams, panels & more
  • ✓ The Lancet gets notified by email
  • ✓ Fee held in escrow, released after the appearance
See Pro $9.95/mo →

Already Pro? Log in.

Auto-generated from X's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove

✉️ Contact